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SUMMARY
Dogs sera samples collected from Cotia County, São Paulo were tested using indirect immunoenzymatic test (ELISA) in order
to study Lyme disease serology in dogs. ELISA method was standardized and G39/40 North American strain of Borrelia burgdorferi
was used as antigen. Positive results were confirmed employing the Western blotting technique. Because of the possibility of cross-
reactions, sera were also tested for different serological strains of Leptospira interrogans and L. biflexa using microscopic sera
agglutination test. Twenty-three of 237 (9.7%) serum samples were positive in the ELISA; 20 of them (86.9%) were confirmed by
the Western blotting, what suggests that Cotia may be a risk area for Lyme disease. Although 4 samples (1.7%) were positive for
Lyme disease and leptospirosis, no correlation was found between the results (X2 = 0.725; p = 0.394) what suggests absence of
serological cross reactivity.
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INTRODUCTION
Lyme disease is a multisystemic zoonotic disease caused by a tick-
borne spirochete Borrelia burgdorferi16. The disease in humans typically
begins with a skin rash named erythema migrans, and is often associated
with flu-like symptoms that may be followed weeks to months later by
cardiac, neurological, and joint disease22.
Many Borrelia strains have been isolated from Ixodes sp. ticks,
reservoir animals and Lyme disease patients in many parts of the world.
B. burgdorferi sensu latu, that was first thought to be a homogeneous
species, is classified into new genospecies: B. burgdorferi sensu strictu
isolated in North America and Europe, B. garinii and B. afzelli in Europe,
B. japonica in Japan, and B. andersonii in North America2.
Borrelia burgdorferi has been isolated and identified in many
different animal species10, yet clinical manifestations of the disease have
been reported in dogs, horse and cattle6,7,12. Affected dogs may exhibit a
variety of clinical signals including fever, lethargy, lymphoadenopathy,
kidney disorders, heart block and recurrent polyarthritis, the latter being
the most frequent manifestation in seropositive animals12. Due to a lack
of pathognomonic clinical signals, serology has been widely used for
the diagnosis of canine borreliosis, and has been a helpful tool for
epidemiological surveys. Indirect fluorescent antibody test (IFA) and
enzyme immunosorbent assay (ELISA) are used in humans and dogs to
test for exposure to Borrelia burgdorferi, and for confirmation, Western
blotting assay8.
In areas where Lyme disease is endemic, the prevalence of antibodies
to B. burgdorferi in dogs is higher than in co-resident human population9.
This probably is because dogs are more exposed to the vectors, which
remain longer on the host making easier the transmission of the
spirochetes. For this reason, dogs are considered as sentinel animals, as
a means of determining the prevalence of Lyme disease in a geographic
area.
In Brazil, there are reports of clinical cases in humans patients,24,26,27,28
and Cotia County in São Paulo State was the first region where disease
was identified in brothers, and the diagnosis was confirmed by the
presence of B. burgdorferi antibodies revealed by ELISA and Western
blotting tests. Seroepidemiological study performed in this area25 revealed
that about 7.5% of the people were seropositive, similar prevalence
observed at risk areas in North America and Europe15 .
Despite of the known existence of human infection, no data was
available for dogs disease in the same area, so to fulfil this gap, the
seroprevalence of B. burgdorferi in dogs was studied, using indirect
ELISA technique, and confirmation of positive samples by the Western
blotting method.
MATERIAL AND METHODS
Sera: During anti-rabies vaccination campaign in Cotia County (São
Paulo, Brazil), 237 sera samples from dogs of any age, gender and breed,
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owned near the woods were collected, from August 18th to September
1st, 1992. Informations related to previous or recent contact with ticks
were obtained for all dogs.
ELISA METHODS
Antigen: For antigen preparation it was used Borrelia burgdorferi
G39/40 strain of North American origin, maintained at Laboratório de
Investigação em Reumatologia da Faculdade de Medicina da
Universidade de São Paulo. The preparation of whole sonicated
spirochetes suspension was made as previously described3. Briefly,
microorganisms were grown in Kelly’s modified medium for
approximately one week at 33 °C. At late-log-phase growth, organisms
were pelleted by centrifugation at 12000 g for 20 min at 4 °C, washed
with a solution of cold PBS 0.001M MgCl2 6H2O PBS (pH 7.4) and
sonicated on ice for 3 min with 15 sec intervals with a cell sonicator
(Sonic Dismembrator Model 300, Dynatech Lab, Inc).
The suspension was filtered (0.45 m diameter pore) and the protein
concentration was determined by the method of Folin. The antigen
preparation was stored in aliquots at -70 °C until use.
Positive control serum: To obtain a positive control serum, a dog
without serum antibodies against Borrelia burgdorferi (Canine B.
burgdorferi antibody test kit, Cite) and L. interrogans (Microscopic sera
agglutination test) was inoculated twice, with a 7 days interval, with a
heat killed (56 °C – 30 min) B. burgdorferi suspension at a dose of 0.1
mg/Kg of body weight.
The antigen suspension was prepared as above described but was
not submitted to sonication, and 0.5 ml of the suspension was
homogenizated with 0.5 ml of complete Freund’s adjuvant and inoculated
subcutaneously.
Serum samples were collected 4, 7, 10, 14, 21, 36, 44, 58 and 64
days after the first inoculation and tested for the presence of antibodies
to B. burgdorferi using ELISA and Western blotting methods. Sample
collected on day 36 was chosen as the standard positive control.
Antibodies against L. interrogans were tested by microscopic sera
agglutination assay.
Negative control sera: Sera from eight dogs, free for ticks and
negative for Borrelia (Canine B. burgdorferi antibody test kit, Cite) and
Leptospira antibodies (microscopic agglutination test) were used as
negative controls.
ELISA: The ELISA was performed by standard method23 with
modifications. Briefly, the microtitrations plates (EIA/RIA plate, Costar)
were coated with 200 l of a 0.015 mg/ml solution of the spirochete proteins
diluted in 0.05M sodium carbonate (pH 9.6) and incubated overnight at
4 °C. The plates were then washed three times with PBS containing 0.05%
Tween 20 and blocked with PBS Tween 20 and 5% skimmed milk (pH 7.4).
The wash procedure was repeated and test samples and control sera were
diluted in blocking solution and plated in duplicate (200 l/well). The samples
and negative control sera were diluted 1/400 and the positive control serum
was diluted using serial two ratio dilutions starting on 1/400. After incubation
at room temperature for 1 hour, the wash procedure was repeated and the
conjugate was added (alkaline phosphatase conjugated rabbit serum anti-
dog IgG, Sigma) diluted 1/1000 in blocking solution. After incubation and
wash procedure was added the substrate p-nitrophenyl sodium phosphate
substrate (Sigma) diluted at 1 mg/ml in glycine buffer (pH 10.5). The plates
were read at 405 nm in a Titertek Multiscan MCC/340 (Flow Laboratories),
when the first dilution of the positive control serum reached the optical
density value near 1.0.
Cut off value was obtained by considering the mean optical density
plus three standard deviations of the eight negative controls sera. Optical
densities higher than cut off values were considered positive and the
titers were estimated by regression curve.
Western blotting (WB): Electrophoresis and immunoblotting were
done as previously described with modifications14. Briefly, 750 g of
spirochete proteins, reduced with SDS, was electrophoresed (Mini-
Protean II System, Bio Rad) on a 10% acrylamide gel. After running,
gel proteins were transferred to nitrocellulose paper over night (Mini-
Trans Blot System, Bio Rad), and the paper cut in strips, which were
washed in distilled water. One strip containing Borrelia burgdorferi
antigens and other with molecular weight markers were separated and
stained with a solution 1:1 of colloidal gold (Bio Rad). The others strips
were blocked with 0.1% TBS Tween 20 and 5% skimmed milk for
1 hour at room temperature and then washed five times with 0.1% TBS
Tween 20. The sera samples to be tested (positive and negative controls,
and test sera), were diluted 1:100 in blocking solution and added to
incubate with strips for 1 hour at room temperature. After washing, the
strips were incubated for 1 hour with alkaline phosphatase-conjugated
rabbit serum anti-dog IgG (Sigma Chemical) diluted at 1/1000 with
blocking solution. Washing was repeated and substrate consisting of
NBT/BCIP diluted in bicarbonate buffer pH 9.8 was added. The reaction
was blocked when positive control developed color.
Microscopic sera agglutination reaction: Study on antibodies to
the main sorovars of Leptospira interrogans and L. biflexa was performed
in the Laboratório de Zoonoses do Departamento de Medicina Veterinária
Preventiva e Saúde Animal da Faculdade de Medicina Veterinária e
Zootecnia da Universidade de São Paulo, using the microscopic sera
agglutination technique11.
Statistical analysis: The chi-square test was used in order to evaluate
the correlation between positive results for Lyme disease and positive
results for leptospirosis and to verify the presence of significant
differences between distribution of positive animals, using the indirect
ELISA test, according to gender, age and history of contact with ticks.
RESULTS
A total of 23 (9.7%) of the 237 serum samples analysed by ELISA
had antibodies to Borrelia burgdorferi at a dilution of 1/400 or higher
(Table 1). Although a higher frequency (69.6%) was found on males
when compared to females (30.4%) no difference among them could be
find (p = 0.417). Also, no difference on the frequency of reagents was
observed related to age of dogs (p = 0.256) (Table 2). On the other hand,
positive results were found mainly in dogs with history of previous
contact with ticks (p = 0.034) (Table 3).
When ELISA positive sera were submitted to Western blotting, all
samples except three (86.9%) presented reactivity to more than five bands,
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according to GREENE et al., 199113 standardization confirming the
presence of Borrelia burgdorferi antibodies (Fig. 1).
The microscopic seroagglutination test for leptospira antibodies,
showed that 24 of 237 sera (10.1%) had positive reaction, with titer
ranging from 1/100 and 1/400 for several serovars of Leptospira
interrogans. Only four samples (1.7%) of the 237 gave positive serology
for Lyme disease and leptospirosis. No correlation (p = 0.394) between
both diseases regarding cross reactivity could be found.
DISCUSSION
Lyme disease is an emerging disease in Brazil, and seems to be
endemic in some areas where ticks and wild animals are present, close
to human residents.
Cotia county is located near from São Paulo city and has a vast
wooded area named Atlantic Forest. Epidemiological studies performed
at this region, where first cases of Lyme disease in humans had been
described25, revealed presence of potential vectors4 such as ticks of species
Ixodes loricatus, I. didelphidis and Amblyomma cajennense. Spirochete
like organisms were identified in the blood culture of wild animals and
ticks, however these microorganisms did not grow longer in BSK
medium1.
Seroepidemiological surveillance done at Cotia county revealed a
prevalence of 7.5% of positive results for Borrelia burgdorferi antibodies,
suggesting that residents of the area had previous contact with
spirochetes25 .
The prevalence found here in dogs (9.7%), slightly higher than the
human’s one, confirmed the possibility of transmission of B. burgdorferi
sensu latu to dogs, although no clinical case of Lyme disease had been
observed. The low prevalence of reagents, when compared to some
endemic areas in USA5, where as high as 53% of dogs were found to be
positive for B. burgdorferi, might be due to a low rate of infected ticks.
Also, in areas where Lyme disease is endemic, the seroprevalence for
Lyme disease in dogs is higher than the one found in co-resident human
population9, and low prevalence in dogs was found around the world,
where human cases of disease are rarely described.
The incidence of B. burgdorferi infection in dogs20 is closely related
to the ticks density in a given area, the rate of tick infection and outdoor
or indoor habits of dogs. Also, to the sensitivity and specificity of the
surveillance method employed17.
A decrease in the sensitivity of the method may have occurred because
of the antigen employed. It is known that there are antigenic differences
among B. burgdorferi sensu latu strains isolated around the world19. In
this study G39/40 strain of B. burgdoferi of north American origin was
used, because native isolate was not isolated in Brazil yet.
During introduction of ELISA test for B. burgdorferi antibodies
search in dogs, some difficulties were found. Because of not existence
of positive control serum, a dog previously known to be free of Borrelia
sp antibodies tested by commercial ELISA was inoculated with killed
microorganism plus Freund’s adjuvant twice. The use of alive spirochetes
was avoided to prevent any risk of bacterial dissemination to the
Table 1
Distribution of dogs reagent to B. burgdorferi antigens using ELISA test,
according with gender
Gender
ELISA Males Females Total
Positive 16 (69.6%) 7 (30.4%) 23 (100.0%)
Negative 125 (58.4%) 89 (41.6%) 214 (100.0%)
Total 141 (59.5%) 96 (40.5%) 237 (100.0%)
Table 3
Distribution of dogs reagent to Borrelia burgdorferi antigens using the ELISA
test, according to history of previous contact with ticks
History of contact with ticks
ELISA Contact No contact Unknown Total
Positive 16 (69.6%) 7 (30.4%) 0 23 (100.0%)
Negative 90 (42.1%) 115 (53.7%) 9 (4.2%) 214 (100.0%)
Total 106 ( 44.7%) 122 (51.5%) 9 (3.8%) 237 (100.0%)
Table 2
Distribution of dogs reagent to Borrelia burgdorferi antigens using the ELISA
test, according with the age
Age
ELISA 6 to 11 months 1 to 5 years 6 to 10 years Total
Positive 2 (8.7%)   16 (69.6%)   5 (21.7%)   23 (100.0%)
Negative 24 (11.2%) 168 (78.5%) 22 (10.3%) 214 (100.0%)
Total 26 (11.0%) 184 (77.6%) 27 (11.4%) 237 (100.0%)
Fig. 1 - Western blotting results for sera of dogs from Cotia. A- Borrelia burgdorferi antigens
stained with colloidal gold; B- positive standard serum; C to I- positive test samples; J-
negative sample.
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environment, despite of employment of a non virulent strain of Borrelia
burgdorferi.
The successful production of specific antibodies was confirmed by
ELISA and WB methods, and curiously the immunoblotting showed
different humoral reactivity between the serum obtained from sensitized
dog and positive test samples from the region of Cotia. This data
suggested the presence of a different etiological agent in Brazil.
As WB is a more specific method for Borrelia burgdorferi antibodies
detection, it was used to confirm the results of ELISA test of samples
and controls. It was considered positive WB, when the assay showed
reactivity to at least 5 bands13. Twenty of 23 (86.9%) positive test samples
at ELISA were confirmed by Western blotting assay, revealing good
correlation between these methods. The remaining three samples and
eight negative controls sera were considered negative for B. burgdorferi
antibodies by WB analysis.
The possibility of cross reaction between Borrelia burgdorferi and
others spirochetes is likely18. At the present work four sera (1.7%) of the
dogs had presented simultaneous antibodies against both infections, but
no correlation could be found.
SOARES in 199821 studied presence of IgG class antibodies to B.
burgdorferi and Babesia canis in 150 dogs sera from Itaguaí, Rio de
Janeiro, Brazil, and using ELISA test standardized at same way, obtained
similar results, when it was found 30 positive samples (20.0%) for borrelia
antigens, and did not find serological cross-reactivity between these
diseases.
Interestingly, low titers of antibodies to known borrelias such us B.
burgdorferi, B. garinii and B. afzelli are obtained with sera of Brazilian
patients with Lyme disease, becoming difficult the diagnosis of this illness
in our country26,27,28. WB pattern is also quite different, suggesting the
presence of another etiological agent. Spirochete like microorganisms are
seen in peripheral blood and cerebrospinal fluid of patients with borreliosis,
however are uncultivable and not identified by PCR assays1,28. The present
work done in dogs from risk area for Lyme disease, confirms data obtained
in humans, supporting the idea of existence of a slightly different clinical
entity in Brazil, which has been named as Lyme like disease.
RESUMO
Pesquisa de anticorpos anti- Borrelia burgdorferi em cães da
região de Cotia, São Paulo, Brasil
Com a finalidade de estudar a ocorrência da doença de Lyme em cães
no Brasil, o teste imunoenzimático (ELISA) indireto, utilizado para o
diagnóstico da doença no homem, foi padronizado para a espécie canina.
Utilizou-se como antígeno a cepa americana de Borrelia burgdorferi G
39/40. Os soros de cães procedentes da região de Cotia, área de risco para
ocorrência da doença de Lyme, foram testados e os resultados positivos
foram confirmados através da técnica de “Western blotting”. Para
investigação de possíveis reações cruzadas, os soros foram também testados
para diferentes variantes sorológicas de Leptospira interrogans e L. biflexa
pela técnica de soroaglutinação microscópica. Dos 237 soros testados pela
técnica de ELISA, 23 (9,7%) foram positivos, sendo que 20 (86,9%) destes
soros foram também positivos pela técnica de “Western blotting”, sugerindo
que a região de Cotia seja área de risco para doença de Lyme. Embora 4
(1,7%) dos soros testados apresentassem positividade para doença de Lyme
e para leptospirose concomitantemente, não foi observada associação entre
estes resultados (X2 = 0,725 e p = 0,394), sugerindo ausência de reatividade
sorológica cruzada entre as duas enfermidades.
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